Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses
about
The Cryptococcus neoformans capsule: a sword and a shield.Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasionVaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in miceCryptococcus neoformans gene expression during experimental cryptococcal meningitisTranscriptional regulation by protein kinase A in Cryptococcus neoformans.Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosisInteraction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule.The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans.Characterization of two novel cryptococcal mannoproteins recognized by immune sera.Exploiting fungal cell wall components in vaccinesA yeast under cover: the capsule of Cryptococcus neoformans.Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity.Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.Isolation and purification of antigenic components of CryptococcusVaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses.Protective efficacy of antigenic fractions in mouse models of cryptococcosis.Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformansProtective immunity against cryptococcus neoformans infection.Proteomic analysis of Candida albicans cell walls reveals covalently bound carbohydrate-active enzymes and adhesins.The capsule of the fungal pathogen Cryptococcus neoformans.A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.Cryptococcus antigens and immune responses: implications for a vaccine.Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells.Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.Inositol Polyphosphate Kinases, Fungal Virulence and Drug Discovery.A Call to Arms: Quest for a Cryptococcal Vaccine.Peeling the onion: the outer layers of Cryptococcus neoformans.Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB/c mice.IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans
P2860
Q24619875-5E8E2466-D320-46EF-8668-0DF7BBF19522Q28475575-8FC91D0F-3CBC-4DDE-BA4C-E08A6E753D6AQ28541882-960F609C-6BBA-441B-B657-23238622FE95Q31031908-3E9C5B06-2C64-4B67-8257-19479145A162Q33279161-286B82DF-A462-46EC-A797-88B55B82DE40Q33499671-F0C989C4-402F-4ED7-9AF9-EBBEC2E8F054Q33533286-CBE7490C-CA2D-4EC6-860E-31E15A27A7D9Q33683735-145B6DC0-139E-401E-8797-C25A02268D6FQ34111740-C8822598-E08A-4A73-A780-CD209F8531C0Q35085200-F2B51A36-4A33-483C-A4C5-EF67107A08CCQ35197202-65AD0CF9-179F-4DC3-9E6E-3B6F0685E69AQ35676308-F238E181-6886-48C9-B9A7-CDA2485806AAQ35802553-2AF3496E-3EA5-4B89-9A71-529D4D889E2BQ35813386-9845DB6E-656C-4805-ADD5-43004F00F681Q36192774-C2645666-133C-4690-B4B5-3911268A96EDQ36431583-21B417D2-6612-4823-9CAA-4DAC8EDE5652Q36551864-04D9723A-E542-4997-AA46-68F2ADE8078AQ36576482-EED8B7F0-5564-46CD-8632-6271B32D156AQ37033075-0BB45DF8-2659-45B1-897E-3C68B5AB0E61Q37181729-A6CAC3A3-44E3-462A-ABEC-ACED77262914Q37227011-97C7B531-7CFD-46C9-8C51-5FEA69242A50Q37337879-E63E02AD-300D-4D3D-99C7-860831E193D1Q37367575-4BC6C194-6BA2-4FDE-B627-232721C1B25EQ38155197-61204BE4-DDFD-4F89-A667-43312ABEA32AQ38959578-61C9BF0D-EB24-4AA2-BD6C-100BA72B0C57Q46252449-4F2D1183-92A5-47C0-9CFD-335D98481E7FQ48149189-1056F26C-A8E6-4C5A-890C-3A4BE480E931Q50149203-62049119-1F3C-4ECE-8D40-24832B494E25Q55056045-95FBF4E9-A64C-41EA-9490-579B40A0C970Q55056060-CC27460C-24A8-40C0-A7B5-A74B0A1529A6Q57286224-FDAABC0A-E116-49B6-8004-5EF43AAB0667
P2860
Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Purification and characterizat ...... at stimulates T-Cell responses
@ast
Purification and characterizat ...... at stimulates T-Cell responses
@en
Purification and characterizat ...... at stimulates T-Cell responses
@nl
type
label
Purification and characterizat ...... at stimulates T-Cell responses
@ast
Purification and characterizat ...... at stimulates T-Cell responses
@en
Purification and characterizat ...... at stimulates T-Cell responses
@nl
prefLabel
Purification and characterizat ...... at stimulates T-Cell responses
@ast
Purification and characterizat ...... at stimulates T-Cell responses
@en
Purification and characterizat ...... at stimulates T-Cell responses
@nl
P2093
P2860
P1476
Purification and characterizat ...... at stimulates T-Cell responses
@en
P2093
Chao Huang
Charles A Specht
Michael K Mansour
Shu-Hua Nong
Stuart M Levitz
P2860
P304
P356
10.1128/IAI.70.10.5485-5493.2002
P407
P577
2002-10-01T00:00:00Z